AMN Healthcare Services (AMN) Q2 Earnings Report Preview: What To Look For

AMN Healthcare Services (NYSE: AMN) is set to report Q2 results Thursday after market close. The article notes last quarter’s revenue of $1.38B, up 99.9% year over year, and a revenue/EPS beat. For this quarter, analysts expect revenue down 4.5% y/y. The average analyst price target is $31.86 versus a $33.24 share price.

Original reporting
Published Aug 5, 2026, 4:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 4:23 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMN Healthcare Services (AMN) Q2 Earnings Report Preview: What To Look For — source image
Decision brief

The 30-second read

$AMNNeutralMed
01

Why it matters

Traders can use the stated consensus revenue decline (4.5% YoY) and AMN’s prior beat history to gauge whether the upcoming report is likely to surprise and how much earnings volatility to expect.

02

Market read

The article is primarily a setup for AMN’s upcoming earnings, highlighting consensus revenue expectations and mixed peer signals.

03

What to watch

The preview emphasizes revenue YoY direction but does not discuss margin, utilization, or guidance details, which often drive the post-earnings move.

Relevance 4/10Novelty 3/10Timing: pre-market positioning ahead of AMN’s earnings Thursday after the close

Background

AMN Healthcare Services is scheduled to report Q2 results Thursday after market close; the article frames consensus expectations and peer outcomes.

Company-level read

Ticker impact

$AMNNeutralMedium confidence
Context

AMN is set to report earnings Thursday after the close, with consensus expecting revenue down 4.5% YoY and prior-quarter results cited.

Expected impact

Likely volatility around the release, with upside if revenue decline is smaller than 4.5% and downside if it worsens versus expectations.

Evidence & confidence

The article provides specific consensus framing (revenue down 4.5% YoY) and notes AMN’s prior beat history, but it does not disclose any new AMN-specific datapoint beyond what is already expected.

Market effects

Peer results (Pediatrix growth beat, Ensign miss) provide limited directional context for healthcare staffing/providers sentiment into the quarter.

No specific regional impact described.

No global macro or cross-border catalyst described.

Counterpoint

Peer read-through may be misleading because staffing demand and payer mix can diverge materially across providers, so AMN’s outcome may not track the segment average.

Key entities

  • AMN Healthcare Services

    Subject of the earnings preview, scheduled to report Thursday after the close.

  • Pediatrix Medical Group

    Peer cited as having delivered YoY revenue growth of 4% and a beat versus expectations.

  • The Ensign Group

    Peer cited as having revenues up 10.7% but missing estimates, with shares up 5.9% after results.

Related articles

$AMNHighAI 9/10

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS

AMN Healthcare Services (NYSE: AMN) reported Q2 2026 revenue of $673 million, up 2% year over year, and adjusted EBITDA of $73 million. GAAP net income was $21 million, or $0.53/share, and adjusted EPS was $0.77. The company said results exceeded guidance, citing travel nurse and allied growth, 27% search revenue growth, and acquisitions expanding AI and leadership offerings. Q3 revenue is expected 1-3% higher.

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.

$GPNMed

Global Payments Q2 Earnings Call Highlights

Global Payments (NYSE:GPN) reported Q2 results and discussed its Worldpay integration and Genius point-of-sale rollout. Management guided for about 4.5% revenue growth in 2H, margins near 43%, and cited drivers including sales-force ramp and enterprise go-lives. Q2 adjusted net revenue by segment: SMB $1.51B, Enterprise $838M, Platforms $628M. Adjusted free cash flow was $687M; net leverage just below 3.5x.